Respiratory infections reduced by 63 percent with 4000 IU vitamin D daily - RCT

Highlights of Report in Swedish translated by Google

  • Peter Bergman and his colleagues are fortunate to have 140 patients in daily treatment for one year with either vitamin D (4000 IU) or a placebo.

  • The study was double-blind: neither the patients - all of which were susceptible to infections - nor caregivers knew who belonged to which group before the trial was over.

  • The results show that vitamin D reduced patient discomfort.

  • The probability of requiring treatment with antibiotics during the study period was63 % lower in the vitamin D group compared with the placebo group, and the incidence of fungal infections, including respiratory, decreased.

    Chart from 2015 publication

image

Note: if takes ~100 days for the vitamin D levels to plateau (thus, no benefit is expected until then)

Respiratory tract infection eliminated in 36 percent of people

Types of Respiratory Infections

image

Vitamin D did particularly well with

  • Moraxella catharralis

  • Staphylococcus aureus

  • Pseudomona aeruginosa

  • Fungal infection

Adverse effects: fewer with vitamin D than with placebo

image

Suspect that Vitamin D caused the reduction in:

  • Gastrointestinal

  • Cardiovascular

  • Infections

The RTI aspects

image

📄 Download the English 2012 PDF from VitaminDWiki

📄 Download the English 2015 PDF from VitaminDWiki


See also VitaminDWiki

image

See also web